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Gestational Diabetes Mellitus (GDM) accounts for 90-95% of all cases of diabetes in 
pregnancy. Family history, obesity and insulin resistance are some of the risk factors 
of GDM. GDM complications that affect the mother, baby and infant can be long-term 
or short-term. 
 
The purpose of this thesis is to describe the nursing interventions in the management 
of GDM in prenatal care patients. 
 
The method used in this thesis is a literature review with an inductive qualitative 
content analysis. To gather important literature that is up-to-date, two databases 
were searched. These are Laurea FINNA and Sage Premier 2012, and a total number 
of 24 articles accepted. 
 
Four main categories in the management of GDM were derived from the data ana-
lysed. These include; self-care management, medication, education and training, and 
social support. It was deduced from the data that there is a distinct lack of 
knowledge amongst pregnant women with GDM on how to implement a self-care 
management plan in their daily living. As a result, depression, stress, anxiety and 
eating disorders arise.  
 
In conclusion, effective management and reduction in the prevalence of GDM is 
through self-care management. A well-balanced diet through the Medical Nutrition 
Therapy (MNT) is a chief foundation of managing GDM. Nurses play an important role 
in counseling and educating women with GDM by providing indepth information on 
nutrition as stated by a clinical dietician. Nurses require further education and train-
ing on the general knowledge, management and prevention of GDM.  
 
Aspects such as language and culture should be put into consideration when educat-
ing both GDM pregnant women and professional healthcare team in order to have a 
good comprehension in the effective management of GDM .  
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1 Introduction  
International Diabetes Federation, IDF (2015) states that 415 million individuals have 
diabetes at the moment and is foreseen to increase to 642 million by 2040. A disturbing 
figure of 193 million people with diabetes are presently not identified by healthcare 
professionals. In 2015, diabetes caused the death of 5.0 million people (IDF 2015). ”Of 
all types of diabetes, Gestational Diabetes Mellitus (GDM) accounts for approximately 
90-95% of all cases of diabetes in pregnancy” (ADA 2009; Landon & Gabbe 2011) and is 
perceived as a rapidly increasing health concern throughout the world (Ferrara 2007; 
Bener, Saleh & Al-Hamaq 2011). 
 
According to Moss, Crowther, Hiller, Willson, and Robinson (2007), the burden that GDM 
places on both the individual and the healthcare system financially is undisputable. Ap-
proximately 817 dollars is spent on treating one case of GDM for diet-treated clients and 
3000 dollars for insulin-treated clients (Moss et al 2007). Fallah, Chen and Lefebrve 
(2011) and Canadian Institute for Health Information (CIHI) (2013) state that the mean 
value spent on GDM complications in areas of cesarean section and neonatal intensive 
care admission in Canada is 4000 dollars and 7000 dollars accordingly (Fallah et al 2011; 
CIHI 2013).  
 
König, Junginger, Reusch, Louwen and Badenhoop (2014, 42) state that ”in 2013, more 
than 21 million live births globally were affected by diabetes during pregnancy, with 
more than 79,000 children developing type 1 diabetes (T1DM)” (König et al. 2014, 42). 
Most pregnant women with GDM recuperate after child birth (Skupien, Cyganek & Mal-
ecki 2014) while 50% can develop type 2 diabetes mellitus (T2DM) within 20 years (Cun-
ningham, Leveno, Bloom,Hauth, Rouse & Spong 2010; Ferrara 2007). GDM can return in 
future pregnancies in women that have had GDM (Kim, Berger & Chamany 2007). 
 
One of the writers witnessed a scenario in Africa, where a friend of hers gave birth to a 
big baby through natural birth, thereby disfiguring the baby. This captured our interest 
on the chosen topic, so as to acquire more knowledge on GDM that can be applied in 
some of the hospitals back home . The purpose of this thesis is to describe the nursing 
interventions in the management of gestational diabetes in prenatal care patients so as 
to manage or prevent complications for the mother and baby and to prevent the other 
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types of diabetes (T1DM and T2DM) from occurring. Literature review will be used to 
compile known information on the topic.  
2 Concepts 
The main concepts of the thesis are defined and explained in this chapter. 
   
2.1 Gestational Diabetes Mellitus (GDM) 
GDM is defined as glucose intolerance that is first identified during pregnancy (ADA 
2012; Landon 2009 & IDF 2013). This means that pregnant women with GDM had no dia-
betes before pregnancy according to the definition. The breakdown of glucose in the 
body is performed by the hormone, insulin. Insulin maintains maternal metabolism and 
during pregnancy, it’s physiology is altered (Lowe & Karban 2014) due to hormonal 
changes. These hormones (estrogen, progesterone, prolactin, cortisol and growth hor-
mones) prevent insulin from functioning by blocking it, thereby making it resistant (Feig 
2008). The beta cell stores and releases insulin in the body but when isulin becomes re-
sistant, beta cell becomes insufficient to surmount it’s resistance (Metzger, Lowe, Dyer, 
Trimble, Chaovarindr, Coustan, Hadden, McCance, Hod, Mclntyre, Oats, Persson, Rogers 
& Sacks 2008), resulting in the development of GDM (Kapustin 2008). Insulin resistance 
is at its peak during the second and third trimesters of gestation (Feig 2008). 
 
The prevalence of GDM in some countries is as follows: 4-10% in the United States of 
America, 5% in the United Kingdom (Agarwal, Dhatt & Shah 2010; Gandhi, Bustani, 
Madhuvrata & Farrell 2012), 28% in Nepal, <1% in Germany (Jiwani, Marseille,Lohse, 
Damm, Hod & Kahn 2012), 11.1% in Malaysia (Ravichandran & Karalasingam 2009), 5% in 
Australia (Australian Institute of Health and Welfare (AIHW) 2010), 6.8% in China 
(Zhang, Dong, Zhang, Li, Wen, Gao & Hu 2011), 4.9% in Iran (Sayehmiri, Bakhtiari, Dar-
vishi & Sayehmiri 2013), and 10.3-11.2% in Finland (Lamberg, Raitanen, Rissanen & Luo-
to 2012). As regards to GDM in Africa, the calculated rate per hundred is unclear due to 
the type of screening method adopted in relation to cost (Jiwani et al.2012). GDM pre-
valence rate differs globally due to different diagnostic criteria and individual traits 
(Galtier 2010). 
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2.1.1 Risk factors 
The risk factors for GDM are family history of GDM or T2DM, maternal age over 30-35 
years, obesity (Carolan 2013), maternal overweight, insulin resistance, maternal meta-
bolic syndrome (Chu, Callaghan, Kim, Schmid, Lau, England & Dietz 2007), minority race 
and low socioeconomic status (Link & McKinlay 2009), lack of vitamin D (Senti, Thiele, & 
Anderson 2012), prior parturition of a baby greater than 4000g, polycystic ovary disease, 
previous newborn death, previous delivery through surgery, large amount of bad chole-
sterol in the food, prior stillbirth, hypertension during gestation, and multiple gestation 
(Ashwal & Hod 2015). 
2.1.2 Screening and Diagnosis 
Screening for GDM is usually done within 24-28 weeks of pregnancy through the one-step 
approach of using fasting Oral Glucose Tolerance Test (OGTT) (Leary, Pettitt & Jo-
vanovic 2010) and the two-step approach. In the two-step approach, both the glucose 
challenge test (GCT) and OGTT are implemented. In GCT (nonfasting), plasma glucose 
concerntration  or serum is carried out 1h after a typical 50g oral glucose load (Virally & 
Laloi 2010). If the plasma glucose concentration is ³ 7.8 mmol/l, 100g OGTT is perfor-
med on the fasting client (ADA 2014). The various diagnostic guidelines in the determi-
nation of GDM as stipulated by different organizations is shown in table 1. 
 
Organisation Fasting 
Plasma Glu-
cose 
Glucose 
Challenge 
1-h plasma 
glucose 
2-h plasma 
glucose 
3-h plasma 
glucos 
World Health 
Organization 
(WHO) 1999* 
 ³ 7.0 75g OGTT Not re-
quired 
³ 7.8 Not re-
quired 
American 
Congress of 
Obstetricians 
and Gynecol-
ogists 
(ACOG)** 
³ 5.3 100g OGTT ³10.0 ³ 8.6 ³ 7.8 
Canadian Di-
abetes Asso-
ciation 
(CDA)*** 
³ 5.3 75g OGTT ³ 10.6 ³ 8.9 Not re-
quired 
International 
Association 
of Diabetes 
and Pregnan-
cy Study 
Groups 
³ 5.1 75g OGTT ³ 10.0 ³ 8.5 Not re-
quired 
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(IADPSG)**** 
 
* one value is sufficient for diagnosis 
** two or more values are required for diagnosis 
*** two or more values required for diagnosis 
**** one value is sufficient for diagnosis 
Table 1: Most commonly used diagnostic guidelines for GDM (WHO 1999; ACOG 2011; 
CDA 2008 & IADPSG 2010) 
 
According to the table above, the OGTT is carried out after fasting the whole night, 
that is, 8-14 hours. 75g anhydrous glucose is mixed in 250ml-300ml water and taken by a 
pregnant patient after 2 hours. When the plasma glucose is ³ 7.0 , then a person is seen 
to have GDM (WHO 1999) (needs to be updated because it is not evidence-based and is 
over 10 years old). According to ACOG 2011, treatment of GDM depends on 100g , 3hour 
oral glucose tolerance test. Microvascular disease can be determined by fasting  plasma 
glucose rate of 7.0mmol/L with a 2hour glucose value of ³11.1 in 75g oral glucose tole-
rance test (CDA 2008). From the HAPO study on women in the third trimester of 
pregnancy, it was evaluated that fasting plasma glucose ³ 5.8mmoI/l and 2hour plasma 
glucose > 11.1mmoI/I produced data in relation to maternal glycemia and particular si-
de effects in implementing a criteria for diagnozing and categorizing GDM (IADPSG 
2010).  
 
In Sweden, screening of GDM is part of the Swedish Medical Surveillance of Pregnancy 
(Mödrahälsovård 2008). Here, the WHO guidelines  of using 75g oral glucose tolerance 
tests are adopted. GDM is diagnosed when 2h value of blood glucose is greater or equal 
to 9.0mmol/I (WHO 1999). In most third world countries, only pregnant women who are 
at a risk of developing GDM are screened due to financial constraints (Jiwani et al. 
2012). 
2.1.3 Complications 
GDM complications affect the mother, fetus/baby and infants. It can be short-term or 
long-term. For the fetus/baby, there is macrosomia (fetal size greater than 4kg), 
increased rate of stillbirth, birth asphyxia (deprivation of oxygen to a newborn) (Henrik-
sen 2008), birth injury (shoulder dystocia, brachial plexus injuries, clavicle fractures) 
(Chu et al. 2007). There is also decrease in neonatal blood glucose level (hypogly-
caemia) (Reece, Leguizamon & Wiznitzer 2009), polycythaemia (high amounts of red 
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blood cells in the blood) (Hopewell, Steiner, Ehrenkranz, Bizzarro & Gallagher 2011), 
death of newborn (Reece 2010), hypocalcaemia (Hay Jr 2012), low apgar scores (a met-
hod to quickly summarize the health of a newborn). As a result of the above complicati-
ons, the baby is admitted into the neonatal intensive care unit for a longer period of 
time (AIHW 2010).  
 
Infants of GDM mothers are faced with long-term complications such as delayed motor 
development, obesity, diabetes (Hillier, Pedula, Schmidt, Mullen, Charles & Pettitt 
2007; Slining, Adair, Goldman, Borja & Bentley 2010), cardiovascular alterations, hyper-
tension (Simeoni & Barker 2009), malignant neoplasm ( cells that look less like the nor-
mal cell of origin) (Wu, Nohr, Bech, Vestergaard & Olsen 2012), and schizophrenia (We-
gelius, Tuuulio-Henriksson, Pankakoski, Haukka, Lehto, Paunio, Lönnqvist & Suvusaari 
2011).   
 
Complications for the mother with GDM are delivery through surgery, pregnancy hyper-
tension, pre-eclampsia, induced labour (Ju, Rumbold, Willson & Crowther 2008), cardio-
vascular disease, obesity, type 2 diabetes (Kim 2010; Malcolm 2012), GDM reoccurring in 
future pregnancies (Kim, Berger & Chamany 2007), expulsion of fetus, prolonged labour 
pain (Schneidernan 2010), delayed milk production from the mammary glands (Salahu-
deen, koshy & Sen 2013). Mothers with the above complications stay longer than usual 
in the hospital (AIHW 2010). Mothers with GDM are usually anxious, afraid, depressed, 
and concerned about their own health and the health of their unborn baby (Devsam, 
Bogossian & Peacock 2013).  
 
2.2 Prenatal Care 
Prenatal care is the care a woman receives during gestation. Antenatal visits to a health 
care centre involves body examination, ultra sound examination, urine tests, Body mass 
index measurements, blood tests if required (March of Dimes 2011). Midwives provide 
prenatal care for the pregnant clients in Sweden (Mödrahälsovård 2008) and United 
Kingdom (Whitehouse 2010). In Finland, it is the public health nurses and midwives that 
provide care at the maternity clinics (neuvola). In Africa, nurses and midwives provide 
antenatal care. 
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According to the experiences of one of the writers, prenatal care visits in Finland starts 
once the pregnancy has been confirmed positive. The first visit is usually from 7-9 
weeks, second visit 13-14 weeks depending on the municipality, third visit 16-17 weeks, 
fourth visit 22-23 weeks, fifth visit 27-28 weeks, sixth visit 30-31 weeks, seventh visit 
33-34 weeks, eighth visit 36 weeks, ninth visit 37-38 weeks, tenth visit 40-41 weeks if 
required, eleventh visit 42 weeks. If no contractions in the forty-second week, an induc-
tion of labour is done. Most women start parturition from week 38. During the antenatal 
visit, the woman’s weight, blood pressure, hemoglobin, and urine are assessed and re-
corded in the maternity card. The urine is checked for protein and glucose. An ultra-
sound is scheduled for week 12 and week 20 of the pregnancy. The fetus’s heartbeat 
and body size are also observed during the antenatal visits.  
 
Whitehouse (2010) states that up-to-date information on health promotion, disease pre-
vention is provided during antenatal visits for the pregnant clients to make lifestyle 
changes for  better fetal growth and development. The care is designed to discover and 
treat harmful situations during gestation (Whitehouse 2010). In Sweden, clients receive 
care for free, based on the fact that they are funded by taxes (Mödrahälsovård 2008). 
This system of funding and free care also applies in Finland. The routine antenatal care 
timetable from conception to delivery in the United Kingdom is shown in figure 1. 
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Figure 1: The routine antenatal care timetable from conception until delivery (Whitehouse 2010 
Retrieved from the Oxford handbook of general practice 3rd edition) 
 
2.3 Nursing Interventions 
Nursing interventions are systematic research based findings exercised by nurses to be-
nefit the patient (Bulecheck, Butcher, Dochterman & Wagner 2013). In order to achieve 
the required goal, a nursing process needs to be implemented. Nursing process is defi-
ned as a key element for achieving patient centered outcomes (American Nurse Asso-
ciation 2017) through assessment, planning, implementaion and evaluation of nursing 
care. Berman, Kozier and Erb (2010) state that assessment is the systematic and conti-
nuous collection, organisation, validation and documentation of information (Berman et 
al. 2010). Patient’s health needs should be a cornerstone for nursing assessment rather 
than disease pathology (Wilkinson 2007). Nurses are required to make correct and im-
portant observations when assembling, affirming and arranging information together for 
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a collective decision to be made by putting into consideration the physical, psychologi-
cal, spiritual, social and cultural aspects (Dougherty, Lister & West-Oram 2015). 
 
Nursing diagnosis is one’s clinical perception about a certain health or illness leading to 
it’s confirmation (Dougherty et al. 2015). Gathering of meaningful and suitable informa-
tion from the patient provides substantial diagnostic accuracy in a patient’s health care 
path. Planning recognises the nursing patient outcomes and formulates desired nursing 
interventions (Alfaro-Lefevre 2014) which are implemented and later evaluated. Nursing 
and Midwife Council (NMC) 2010 states that the composition and quality of documenta-
tion are a degree of principles of procedure associating to the competence and 
discernment of the nurse (NMC 2010).      
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3 Purpose of the study and Research question 
The purpose of this study is to describe the nursing interventions in the management of 
gestational diabetes in prenatal care patients. The choice of this topic was influenced 
by our desire to acquire better understanding of existing research since we are from de-
veloping countries where there is little knowledge as regards to the topic. 
 
The research question is; What kind of nursing interventions are implemented in the 
management of gestational diabetes in prenatal care patients?  
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4 Methodology 
4.1  Literature Review  
The research method chosen for this thesis is a literature review, which is an evaluated 
summary of other research (Coughlan, Cronin & Ryan 2013, 2). Machi and McEvoy (2009) 
state that ”literature review is a critical appraisal of other research on a given topic 
that helps to put that topic in context” (Machi & McEvoy 2009). Literature review is key 
to establish, notify and summon data that can be used in academic group discussions. 
Reviewing provides a summary of up–to-date knowledge on a given aspect that is not 
based on a personal perspective. Literature review is predated by research question and 
how it is going to be discussed depends on the methodology one uses that may either be 
qualitative or quantitative research (Coughlan et al. 2013, 2). The literature review 
methodology was chosen so as to gather relevant and up-to-date data that can be dis-
seminated to the developing countries especially Africa where we come from. 
 
Engberg (2008) asserts that structured reviews are research studies and like all research 
enquiries, they require explicit and transparent methodology which in turn facilitates 
the aim of reaching an unbiased conclusion ( Engberg 2008). A literature review is gui-
ded by the inclusion and exclusion criteria that must be rationalized in order to yield 
reasonable findings (Coughlan et al. 2013, 38). 
 
4.2 Database Search 
The data search to answer the research question was executed between 20th of June 
2017 and the 31st of July 2017. The databeses used were Laurea Finna and Sage premier 
2012. Laurea Finna retrieves articles from many of the journals that laurea has access 
to such as Cumulative Index to Nursing and Allied Health Literature 
(CINAHL)/EBSCOHost, pubmed, proquest, and Elsevier Sd Freedom collection. Laurea 
Finna is an electronic search portal that belongs to Laurea University of Applied 
Sciences, and Sage premier 2012 is an online database that has so many different scien-
tific journals. Different search words were used so as not to miss out on vital informati-
on/findings. The keywords that were used for this search along with their synonyms we-
re: Gestational diabetes mellitus (pregnancy diabetes/maternal diabetes), nursing in-
terventions (management), and prenatal care (antenatal care). The Boolean operator 
”AND” was used to connect the keywords so as to get data/articles containing all of the 
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keywords used in the search. During the data search, titles and abstracts were scruti-
nized to get data that was relevant to the research question. The total number of arti-
cles that were relevant to the research question is illustrated in table 2. 
 
Search Terms Database Total number 
of articles 
1st Selection 
Stage 
2nd Selection 
Stage 
3rd Selec-
tion Stage 
Nursing Inter-
ventions AND 
Gestational 
Diabetes AND 
Prenatal Care 
 
Laurea Finna 
27 0 0 0 
Sage Premier 
2012 
294 6 3 2 
Nursing Inter-
ventions AND 
Gestational 
Diabetes 
 
Laurea Finna 
1,916 94 31 7 
Sage Premier 
2012 
771 18 5 1 
Nursing Inter-
ventions AND 
Maternal Dia-
betes AND 
Prenatal Care 
 
Laurea Finna 
1,304 29 10 3 
Sage Premier 
2012 
423 5 1 0 
Nursing Inter-
ventions AND 
Pregnancy 
Diabetes AND 
Prenatal Care 
 
Laurea Finna 
1,323 33 12 2 
Sage Premier 
2012 
465 5 0 0 
Nursing Inter-
ventions AND 
Gestational 
Diabetes AND 
Antenatal Care  
 
Laurea Finna  
576 25 11 0 
Sage Premier 
2012 
251 5 1 2 
Gestational 
Diabetes AND 
Prenatal Care 
AND Manage-
ment 
 
Laurea Finna 
4,738 37 22 1 
Sage Premier 
2012 
410 10 5 6 
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Totals Laurea Finna 
 
9,884 218 86 13 
Sage Premier 
2012 
2,614 49 15 11 
 12,498 267 101 24 
 
Table 2: The literature search process, showing the number of retrieved articles and the 
different selection stages 
 
4.3 Inclusion and exclusion criteria 
The search was restricted to full text only (has all the important information), peer re-
viewed articles (trustworthy), english language (easy to comprehend) and published 
between 2007 and 2017 (recent). With the above restrictions, 12,498 articles were ret-
rieved. 267 articles of relevance to the study were chosen after reading the titles and 
abstracts. 101 articles were selected after scanning through the introductions and fin-
dings. 101 articles selected for indepth reading were screeened for duplicates and trip-
licates before analysing them. 24 articles were finally selected based on the fact that 
they were of good quality, and relevant to the thesis. The inclusion and exclusion crite-
ria for the chosen articles are shown in figure 2. 
  
 
 
Figure 2: Data selection process 
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4.4 Data Appraisal 
Young & Solomon (2009) define critical appraisal as ”a logical process used to identify 
the strengths and weaknesses of a research article in order to access the usefulness and 
validity of research findings”. In critical appraisal, a suitable assessment of the study 
plan for the research question and a meticulous evaluation of the methodology for that 
design are the major elements (Young & Solomon 2009). 
 
The strength of the accepted articles were appraised using the Johns Hopkins Nursing 
Evidence-Based Practice Model and Guidelines. It uses a scale of I – V to ascertain the 
strength of the evidence. Scale/level I is regarded as the strongest form of evidence and 
scale/level V, the weakest form of evidence (Newhouse, Dearholt, Poe, Pugh & White 
2007). The strength of the evidence levels I, II, III, IV and V are shown in table 3. 
 
Level Components 
I is characterised by experimental study, randomized controlled trial (RCT), 
systematic reviews of RCTs, with or without meta-analysis 
II consists of quasi-experimental study, systematic review of a combination of 
RCTs and quasi-experimental, or quasi-experimental studies only, with or 
without meta-analysis 
III includes non-experimental study, systematic review of a combination of 
RCTs, quasi-experimental and non-experimental, or non-experimental stu-
dies only, with or without meta-analysis 
IV is made up of opinion of respected authorities and/or nationally recognized 
expert committees/consensus panels based on scientific evidence (clinical 
practice guidelines and consensus panels) 
V comprises experiential and non-research evidence (literature reviews, case 
reports, quality improvement, program or financial evaluation and opinion of 
nationally recognized expert(s) based on experiential evidence) 
 
Table 3: Strength of levels of Evidence (Dearholt & Dang 2012) 
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The quality of the accepted articles were appraised using quality guides A, B or C of the 
Johns Hopkins Nursing Evidence-Based Practice Model and Guidelines. Quality guide A is 
high quality, quality guide B, good quality and quality guide C, low quality. The quality 
guides for levels I, II and III are illustrated in table 4. 
 
Quality Components 
A consists of consistent, generalizable results; sufficient sample size for the 
study design; adequate control; definitive conclusions; consistent recom-
mendations based on comprehensive literature review that includes tho-
rough reference to scientific evidence 
B comprises reasonable consistent results; sufficient sample size for the study 
design; some control, fairly definitive conclusions; reasonably consistent 
recommendations based on fairly comprehensive literature review that in-
cludes some reference to scientific evidence 
C is made up of little evidence with inconsistent results; insufficient sample 
size for the study design; and conclusions cannot be drawn 
 
Table 4: Quality guides of evidence for levels I, II and III (Dearholt & Dang 2012) 
 
The quality guide for level IV is shown in table 5 
 
Quality Component 
A consists of material officially sponsored by a professional, public, private or-
ganisation, or government agency; documentation of a systematic literature 
search strategy; consistent results with sufficient numbers of well-designed 
studies; criteria-based evaluation of overall scientific strength and quality of 
included studies and definitive conclusions; national expertise is clearly evi-
dent; developed or revised within the last 5 years 
B comprises material officially sponsored by a professional, public, private or-
ganization, or government agency; reasonably thorough and appropriate sys-
tematic literature search strategy; reasonably consistent results, sufficient 
numbers of well-designed studies; evaluation of strengths and limitations of 
included studies with fairly definitive conclusions; national expertise is clear-
ly evident; developed or revised within the last 5 years 
C consists of material not sponsored by an official organization or agency; un-
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defined, poorly defined, or limited literature search strategy; no evaluation 
of strengths and limitations of included studies, insufficient evidence with 
inconsistent results, conclusions cannot be drawn; not revised within the last 
5 years 
 
Table 5: Quality guides of evidence for level IV (Dearholt & Dang 2012) 
 
 
The quality guide for level V is shown in table 6 
 
Quality Components 
A is made up of clear aims and objectives; consistent results across multi-
ple settings; formal quality improvement, financial or program evaluati-
on methods used; definitive conclusions; consistent recommendations 
with thorough reference to scientific evidence 
B comprises clear aims and objectives; consistent results in a single set-
ting; formal quality improvement or financial or program evaluation 
methods used; reasonably consistent recommendations with some refe-
rence to scientific evidence 
C consists of unclear or missing aims and objectives; inconsistent results; 
poorly defined quality improvement, financial or program evaluation 
methods; recommendations cannot be made 
 
Table 6: Quality guides of evidence for level V (Dearholt & Dang 2012) 
 
 
 
 
The strength and quality of evidence of the accepted 24 articles is illustrated in table 7. 
 
Level of 
Evidence 
Number of 
Articles 
Quality A 
(High Quality) 
Quality B 
(Good Quali-
ty) 
Quality C (Low 
Quality or Major 
Flaws) 
Level I     
Level II 6 3 2 1 
Level III 4  4  
Level IV 1  1  
Level V 13 9 4  
Total 24    
 
Table 7: Johns Hopkins Nursing Evidence Appraisal 
 
4.5 Data Extraction 
Data extraction takes place before data synthesis in a literature review. Accepted arti-
cles for the research are reviewed thoroughly and the results that are pertinent to the 
research question are extracted. A tested data extraction form should be used when 
extracting relevant data to reduce the risk of bias and errors (Munn, Tufanaru & Aroma-
taris 2014). It is also advised that in the data extraction process, a minimum of two re-
viewers should evaluate the articles independently to reduce the risk of bias and errors 
(Buscemi, Hartling, Vandermeer, Tjosvold & Klassen 2006). After the independent eva-
luation, the authors then come together to compare opinions (Munn et al. 2014). 
 
The two authors reviewed the accepted articles independently and extracted data that 
was relevant into the extraction form such as aims, titles, level of evidence and conclu-
sions of the individual aritcles. The complete analysis of the individual articles are illu-
strated in Appendix 1. 
 
4.6 Data Analysis 
Thorne (2008) describes data analysis ”as the process of moving from pieces to patterns 
through the activities of organizing, reading and reviewing mindfully, coding, reflection, 
thematic deviation and finding meaning” (Thorne 2008).  
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The qualitative content analysis was used to analyze the data and interpret its meaning 
(Schreier 2012). The benefit of qualitative research is the abundance of data put toget-
her and then explained and categorized in a reasonable and genuine way (Moretti, van 
Vliet, Bensing, Deledda, Mazzi, Rimondini & Fletcher 2011). In other words, qualitative 
content analysis reduces the quantity of data, and is flexible (Schreier 2012). It can be 
used either in an inductive or deductive way (Elo & Kyngäs 2008).  
 
For this research, the inductive method was applied. Elo & Kyngäs (2008) state that ”in 
an inductive approach, organization phase includes; open coding, creating categories 
and abstraction” (Elo & kyngäs 2008). Inductive research method necessitates looking 
for designs from inspection and evolution of illustration theories. These designed theo-
ries are acquired through sequences of hypothesis (Bernard 2011). In the inductive ap-
proach, the researcher starts with the collection of data that is relevant to the research 
question. After that, he searches for designs in the data and then creates a theory that 
describes those designs. That is, the researcher moves from distinct data to general 
theory (Blackstone 2012). Illustration of inductive approach is shown in figure 3 
 
 
 
 
 
Figure 3: The inductive approach (Blackstone 2012) 
 
The 24 articles that were accepted from the literature search were read thoroughly, 
and the information gotten were sorted and organized. Data that appeared so many ti-
mes was identified, grouped under subcategories and then broader main categories so 
as to be able to manage the data. Throughout the organizing process, distinctively 
constructed sentences were assigned to each segment of raw data formulating 10 subca-
tegories which were given initial titles. Eventually, 4 main categories with approved tit-
les were generated from the 10 independent subcategories, thus, ending the analysis 
process. The 4 main categories identified are self-care management, medication, edu-
cation and training, and social support . The sorting and organization of data is shown in 
figure 4. 
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Figure 4: The summarized data, subcategories and main categories of the inductive content anaysis 
process 
5 Findings 
The purpose of this thesis is to describe the nursing interventions in the management of 
gestational diabetes in prenatal care patients. In order to achieve this, twenty-four (24) 
articles were reviewed thoroughly and the data obtained is discussed in this section of 
the thesis. The findings consists of 4 main categories, with 10 subcategories as men-
tioned earlier. The management of GDM are: self-care management, medication, edu-
cation and training, and social support as shown in figure 5. 
 
 
 
Figure 5: The 4 main categories in the management of GDM in prenatal care 
 
5.1 Self-care Management 
5.1.1 Nutritional Requirements 
The chief foundation of managing a woman with diabetes during pregnancy is through a 
diet that is well-balanced (Han, Crowther, Middleton & Heatley 2013). The balanced diet 
should comprise carbohydrates, proteins, fats and nutrition diary. The overall quantity of 
calories that is to be consumed per day is determined based on the current and ideal body 
weight of an individual and is known as medical nutrition therapy (MNT). MNT involves the 
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consumption of adequate nutrients and calories that the body requires during gestation. 
Underweight women (BMI < 19.8kg/m2 ) require 35-40 Kcal/kg/day of the ideal body 
weight, normal body weight women (BMI 19.8 - 29.9 kg/m2 )  are to consume 30-32 
Kcal/kg/day of the ideal body weight, overweight women (BMI ³ 30kg/m2) need 24-25 
Kcal/kg/day of the ideal body weight (Bao, Bowers, Tobias, Olsen, Chavarro, Vaag, Kiely & 
Zhang 2014) and unwholesomely obese women, 12 Kcal/kg/day of the ideal body weight 
(Toiba 2013). In a study conducted in south east China by Li, Björn, Hadziabdic, Hjelm & 
Rask (2016), to explore beliefs about health and illness and health-related behaviour 
among urban Chinese women with GDM, it was observed that some women found it chal-
lenging to prepare GDM meal and estimate the quantity of diet correctly. According to a 
participant, she stated that  
 
”She (doctor) asked me to count the food, such as how many grams. How can I count 
every meal?...Sometimes I ate more than her advice; sometimes I ate less than her ad-
vice. I cannot eat exactly the standard meal”. (Sarah) (Li et al 2016, 598).    
 
Meals containing carbohydrate based calories are recommended not to be consumed in 
the morning because insulin resistance is at its peak at that time of the day due to the 
release of cortisol and during gestation, its release is intensified. The diet should comp-
rise three meals and four snacks per day and they should be consumed in little quantity 
to reduce postprandial glucose peaks (Ashwal & Hod 2015). Wholesome carbohydrates, 
for example, fibers (whole grains, fruits and vegetables); dairy foods; and healthy oils 
(monosaturated , polyunsaturated and omega-3 fatty acids) are recommended. Sugar 
sweetened beverages, saturated fats , trans fats and foods high in cholesterol should be 
avoided (ADA 2014). An observational study propose that a smaller consumption of satu-
rated fat, red or processed meat, refined grains, and sweets and a greater intake of fi-
ber, poultry and fish earlier or at the time of gestation results in a decreased prevalen-
ce of GDM (Zhang & Nung 2011; Karamanos, Thanopoulou, Anastasiou, Assad-Khalil, Al-
bache, Bachaoui, Slama, El Ghomari, Jotic, Lalic, Lapolla, Saab, Marre, Vassallo, Savo-
na-Venture & MGSD-GDM Study Group 2014). A larger accumulation of plasma vitamin B-
12, C and D leads to a decreased risk of GDM (Zhang & Nung 2011; Krishnaveni, Hill, 
Veena, Bhat, Wills, Karat, Yajnik & Fall 2009).  
 
A trial study on 6513 nonpregnant women  (Sahariah, Potdar, Gandhi, Kehoe, Brown, 
Sane, Coakley, Marley-Zagar, Chopra, Shivshankaran, Cox, Jackson, Margetts & Fall 
2016) conducted in Mumbai, India to determine whether increasing women’s dietary in-
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take of leafy green vegetables, fruits and milk (micronutrient rich-foods) before con-
ception and throughout pregnancy reduced their risk of GDM. 2291 women became 
pregnant, 2028 reached a gestation of 28 weeks, 1008 were present for an OGTT using 
the WHO 1999 criteria and 100 had GDM. The results of this trial indicated that these 
food constituents had an important protective effect against the development of GDM 
(Sahariah et al 2016). It also stated that leafy green vegetables contain high amount of 
magnesium and a greater consumption leads to reduced risk of T2DM ( Larsson & Wolk 
2007). Intake of large amounts of dairy products reduces the risk of future T2DM due to 
these components; calcium, vitamin D and whey protein (Tong, Dong, Wu, Li & Qin 
2011). 
5.1.2 Physical Activity 
According to van Poppel, Oostdam, Eekhoff,  Wouters, van Mechelen & Catalano (2013), 
physical activity decreases glucose levels, enhances insulin sensitivity and decreases the 
risk of progressing into T2DM without the presence of obesity. In a cinical study con-
ducted (Oostdam, van Poppel, Eekhoff, Wouters & van Mechelen 2009), it was observed 
that physical activity intervention had no effect in the reduction of fasting blood gluco-
se, insulin sensitivity and birth weight on obese and overweight pregnant women at risk 
of GDM in their second and third trimesters (Oostdam et al 2009). In a systematic re-
view, it was identified that physical activity (moderate-to-vigorous intensity physical 
activity, MVPA) before or during pregnancy decreased the risk for GDM (Tobias, Zhang, 
van Dam, Bowers & HU 2011; van Poppel et al 2013; Redden, LaMonte, Freudenheim & 
Rudra 2011). 
 
The United States Department of Health and Human Services, USDHHS (2008) provides 
physical activity guidelines which states that fit women who are not very active or not 
performing vigorous-intensity activity should undertake at least 150 minutes (2 hours 
and 30 minutes) of moderate intensity aerobic activity per week at the time of gestati-
on. The already active gestating women should carry on with the physical activity during 
pregnancy as long as they are fit and should consult with their healthcare worker on 
which exercise that needs to be altered. Shelton (2013) proposes 30 minutes of brisk 
walking three to four times in a week. Snapp & Donaldson (2008) discovered that wo-
men who performed brisk walking three or more times in a week for six or more months 
of gestation had little probability of giving birth to a large for gestational age baby. 
Women that were inactive before should start with arm exercises. Imprudent abdominal 
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exercises that lead to muscle contractions should be avoided during pregnancy. Blood 
glucose level should be monitored before, during and after physical activity to prevent 
activity prompted hypoglycemia.       
5.1.3 Self-monitoring 
Self-monitoring of blood glucose regularly is preferred to irregular monitoring of plasma 
glucose (Magon & Seshiah 2011). Blood sugar is assessed seven times daily (prior to and 
after breakfast, lunch, dinner) and before going to bed at night (Kestila, Ekblad & Ron-
nemaa 2007)  
 
A new monitoring method known as continuous glucose monitoring estimates the 
amount of glucose in subcutaneous interstitial tissue by measuring glucose every one 
second and saving the numerical mean value every five minutes, making the overall 
measurements per day 288. This method identifies a distinctly greater degree of GDM 
women requiring anti-hyperglycemic medication in comparison to self-monitoring of 
plasma glucose. Continuous glucose monitoring acts as a beneficial device in the pro-
longed management of GDM (Kestila, Ekblad & Ronnemaa 2007).  
    
The proposition for weight gain for overweight women during pregnancy is 7kg and for 
underweight women is 18kg (Ashwal & Hod 2015). Pregnant women with GDM should 
frequently check their weight to be sure it lies within the stipulated range. Weight can 
be managed effectively if the diet consumed is well-balanced and the intake of calories 
measured accurately as mentioned in section 5.1.1 to nurture proper weight gain and 
fetal growth (Institute of Medicine and National Research Council 2009). Diets that help 
in weight reduction should be avoided during gestation (IDF 2009). The recommendati-
ons for weight gain during gestation as stipulated by Institute of medicine is shown in 
table 8. 
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Table 8: Weight gain recommendations during pregnancy (Institute of Medicine and Na-
tional Research Council 2009) 
 
The use of telemedicine is aimed at decreasing the number of GDM outpatients’ clinical 
experience (Rasekaba, Furler, Blackberry, Tacey, Gray & Lim 2015). Mobile applications 
used by patients with GDM to acquire true advice on blood glucose monitoring are time-
saving not only to the patient but nurses and doctors as well. MobiGuide run on Android 
gadgets (using computer interpretable guidelines) is a patient directing system-
combining hospital observing data into a personal health record. When the value of ke-
tonuria shows positive, the system will ask if the patient has been consuming authorized 
amount of calories and if yes then advised to increase carbohydrate intake to some 
amount depending on the results. According to observational prospective GDM study in 
2012-2014, a group of women in their 34th week of gestation, older than 18 years, com-
petent with smart phone and computer technology usage were chosen. Through out the 
study, 4561BG measurements, 997 ketonuria values, 369 BP measurements and 184 
exercise data were attained showing that smart telemedicine were well-adapted and 
practicable in assisting GDM patients. Keeping track on required blood glucose observa-
tion was more articulate than in normal care (Rigla, Martinez-Sarriegui, Garcia-Saez, 
Pons & Hernando 2017). 
The use of bluetooth-enabled BG meter through a smartphone app enabled two-way 
communication between the patient and diabetes midwife or physician and is analyzed 
three times a week. Out of the 106 women diagnosed with GDM from 2012-2013 in a pi-
lot survey, 49 participated until delivery and were contented to continue using the 
smartphone application (Hirst, Mackillop, Loerup, Kevat, Bartlett, Gibson, Kenworthy, 
Levy, Tarassenko & farmer 2015).  
 
In a randomized controlled trial in Norway, 230 pregnant women with GDM were given a 
pregnant+ app and standard care and the aim was to assess whether the use of the 
pregnant+ app along with the standard care resulted in improved glucose levels at regu-
lar OGTT. The pregnant+ app mechanically conveys blood glucose figures to the 
smartphone from the glucometer through bluetooth low energy and makes available a 
graphic survey showing if the measurements are within the required range. The app gi-
ves data on healthy diet, general information on GDM and its management and physical 
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activity (has 4 icons: blood glucose, food and beverages, physical activity and diabetes 
information). The results of this study indicated that the pregnant+ app helped the par-
ticipants manage their GDM, for example, if the blood glucose levels are high as shown 
on the graph, the women are able to control the levels. The availability of basic data on 
GDM, important phone numbers and hospital routine on the pregnant+ app reduced 
distress, worries and frequent hospital visits (Garnweidner-Holme, Borgen, Garitano, 
Noll & Lukasse 2015).     
5.2 Medication 
5.2.1 Insulin 
Insulin is a generally accepted treatment method in the medical management of GDM  
(Bone 2015). Medical interventions such as use of insulin in the management of gestati-
onal diabetes mellitus within meal times and at bedtime are more effective than twice 
a day dosage. Research carried out on 322 pregnant women with GDM showed that rapid 
acting insulin is conducive for pregnancy because it lowers postprandial glucose peaks, 
keeps blood sugar under normal-range (Mathieson, Kingsley, Amiel, Heller, McCance, 
Duran, Bellaire & Raben 2007) and maternal hypoglycemia threat lowered by 28% in the 
United States of America (US food and drug Administration 2017). 
Insulin therapy as a supplement to dietary plan is considered when the abdominal cir-
cumference is over the 70th percentile (Kjos & Schaefer-Graf 2007). The quantity of in-
sulin prescribed is based on the body weight (0.7-1.0 Units/kg) of the patient. Insulin 
dosage rises up to 50% from the initial dosage between 20-32 weeks of gestation. The 
mean quantity of insulin in the first trimester is 0.7 Units/kg, in the second trimester 
0.8 Units/kg and in the third trimester 0.9-1 Unit/kg. Insulin can be administered 
through multiple dosage injections or continuous subcutaneous infusion (Ashwal & Hod 
2015).    
5.2.2 Oral hypoglycemic agents 
Oral hypoglycemic agents (glyburide, metformin) are now being seen as the drug of 
choice when GDM is not contained by diet. They are becoming a substitute over insulin 
due to their easy administration, reduced cost, greater approval (Balsells, Garcia-
Patterson, Sola, Roque, Gich & Corcoy 2015) and hypoglycemia and weight gain not oc-
curring (Amin, Suksomboon, Poolsup & Malik 2015). For the management of GDM with 
Oral agents, the National Institute for Health and Care Excellence (NICE) approves met-
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formin, ACOG proposes both glyburide and metformin, and The United States Food and 
Drug Administration has no recommendation yet (Metzger et al 2008).  
 
Glyburide (glibenclamide) increases the insulin output from the pancreatic beta cells, 
broken down by the liver with a peak concentration of 2-3hours and has a half-life of 7-
10 hours (Anjalakshi, Balaji, Balaji & Seshiah 2007). Glyburide is taken 30-60 minutes 
before a meal for better gestational results, has no transplacental passage to the fetus, 
thereby leading to a safe pregnancy (Navneet & Seshiah 2011). The cost effectiveness of 
glyburide in the treatment of GDM is seen to be more than that of insulin. On average, 
the cost saving on glyburide per person was 165.84 dollars (Nicholson, Bolen, Witkop, 
Neale, Wilson & Bass 2009). According to a systematic review done by Dhulkotia, Ola, 
aser & Farrell (2010), both insulin and oral hypoglycemic agents were effective and sig-
nificant in glycemic control and gestation, and thus used as alternatvives of insulin in 
pregnancy. Out of 10,778 women with treated gestational diabetes, the number of tho-
se that used glyburide elevated from 7.4% in 2000 to 64.5% in 2011 (Camelo, Boggess, 
Stumer, Brookhart, Benjamin & Jonsson 2014). 
 
Metformin, an oral substitute agent for insulin can be used together with proper diet, 
exercise programs and other medications to control hyperglycemia in GDM. The fact 
that insulin does not tackle the main problem, insulin resistance, metformin a safe al-
ternative and efficient oral hypoglycemic agent is implemented. Metformin increases 
insulin sensitivity, blood glucose tolerance, decreases the risk of hypoglycmia and 
weight gain. Being in tablet form, metformin is accepted and preferred in most GDM 
pregnant women (Hyer, Balani, Johnson & Shehata 2009). Based on metformin in gesta-
tion study (MIG) 2007, patients with a fasting glucose > 6mmol/L, 1-h postprandial blood 
glucose > 8mmol/L, 2-h postprandial blood glucose > 7mmol/L acquired before break-
fast and 1-2h after meal were introduced to 500mg of metformin twice a day. Results 
showed that most of the patients exhibited a fast improvement in blood sugar levels 
within a week. Those that had a persistent high blood glucose got an addition of insulin 
to treat hyperglycemia (Rowan, Hague, Gao, Battin & Moore 2008).  
5.3 Education and Training 
5.3.1 Healthcare professionals education 
US population predictors, Passel & Cohn (2008) state that ”the fastest growing hispanic 
population at higher risk for diabetes will increase from 14% in 2005 to 29% in 2050” 
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(Passel & Cohn 2008).  Therefore diabetes educationalists must be ready for the expan-
ding growth (United States Department of Health and Human Services Office of Minority 
Health, UDHHSOMH 2015). Aspects such as culture,language are a cornerstone for a suc-
cessful research outcome and goal achievement (Nielsen ,Courten & kapur 2012). 
 
5.3.2 Patient Education 
Self management education is inevitable in the management of gestational diabetes for 
better antenatal outcomes during gestation(Coustan 2013). It has been discovered from 
other studies that most pregnant women with GDM especially in low income countries 
had no knowledge on GDM, its risk factors, preventive measures and lifestyles interven-
tions such as proposed physical activity and well-balanced diet (Poth & Carolan 2013). 
Pregnant women need to have a good knowledge on GDM and the lifestyle interventions 
that manage or reduce GDM and future T2DM. They require education on family plan-
ning to guarantee maximum glycemia control prior to a future conception (Ashwal & 
Hod 2015). Pregnant women should be educated on the weight gain recommendations 
during gestation (Phelan, Phipps, Abrams, Darroch, Schaffner & Wing 2011). They should 
be taught how to read food labels, know the nutritional content of various types of 
foods and drinks (beverages) and right amount of food to be consumed per meal (Sulli-
van 2014). They should be guided on the type of physical activity to indulge in during 
gestation. 
 
Counseling is required for the gestation client to be able to control her diet within the 
public framework, for example, foods in big folk get-together and meals cooked by 
friends and family members (Ho, Tran & Chesla 2015). According to the study conducted 
by Li et al (2016) to explore the beliefs about health and illness and health-related be-
haviour among urban women with GDM in the south east of China, it was difficult for 
some of the participants to adhere to the advice on diet management. According to a 
participant, she stated that  
 
”My mother-in-law cooks for me. It is impossible to tell her I must eat other 
things…The other people will think I am too fussy….I ate what I can eat from the dining 
table”. (Emma)  (Li et al 2016, 593,598). 
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Breastfeeding should be promoted in patients with GDM as it reduces the risk of meta-
bolic syndrome (Hayes 2014; Crume, Ogden, Mayer-Davies, Hamman, Norris, Bischoff, 
McDuffie & Dabelea 2012) and obesity in infants (Crume et al 2012). The advantages of 
breastfeeding for GDM women as demonstrated by studies are: decreases blood glucose, 
lowers the risk of future T2DM (Gunderson, Hedderson, Chiang, Crites, Walton, Azeve-
do, Elmasian, Young, Salvador, Lum, Quesenberry, Lo, Sternfeld, Ferrara & Selby 2012), 
and decreases weight retention (Baker, Gamborg, Heitmann, Lissner, Sorensen & Ras-
mussen 2008).   
 
5.3.3 Written Guidelines 
The Institute of Medicine, IOM (2011) defines clinical written guidelines as ”statements 
that include recommendations intended to optimize patient care that are informed by a 
systematic review of evidence and an assessment of the benefits and harms of alterna-
tive care options”. Written guidelines should be trustworthy and aimed at promoting 
better health outcomes. 
 
IADPSG (2010) assessed a report on the findings of the hyperglycemia and adverse 
pregnancy outcome (HAPO) study on 23,000 pregnant women of different ethnicity. The 
results showed that moderate degrees of high blood sugar during gestation led to an 
increase in macrosomia, caesarean delivery and excessive insulin circulation in the 
blood (neonatal hyperinsulinemia). These findings led to the establishment of the 
prenatal screening guidelines for the diagnosis of GDM.  The recommemndations for 
GDM diagnosis is shown in tables 9 and 10. 
 
  
 
Table 9: IADPSG guidelines for the diagnosis of overt diabetes in pregnancy (IADPSG 
2010) 
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Table 10: IADPSG guidelines for the diagnosis of hyperglycemia in pregnancy (IADPSG 
2010) 
 
The other guidelines for the diagnosis of GDM as recommended by different organizati-
ons are mentioned in table 1.  
 
MNT is a treatment program aimed at achieving an optimal blood glucose level by redu-
cing calorie intake. The program involves counseling, educating, glucose self-monitoring 
in order to manage pre-eclampsia, maternal hospitalization and neonatal death in wo-
men with GDM. During this program, a professional dietician provides the clients with 
individual dietary counseling with indepth education on nutrition (Perera, Nakash, Co-
varrubias, Cano, Torres, Gonzalez & Ortega 2009). Section 5.1.1 explains the MNT re-
commendations for calorie intake during pregnancy. 
5.4 Social Support 
5.4.1 Family Support 
A study carried out in the United States of America indicated that a large number of Af-
rican Americans with GDM were able to modify their lifestyles with the support of their 
loved ones so as to reduce or prevent T2DM (Bieda 2009). In the study carried out by Li 
et al (2016), A participant stated that  
 
”My mother-in-law takes care of me and my husband as well. It is natural that the 
whole family takes care of you because you are pregnant…So the family’s support is 
important” (Anna) (Li et al 2016, 597). 
 
In a qualitative study on the perceived needs in women with gestational diabetes car-
ried out in 2015 in Iran on pregnant women with GDM that are within 24th to 36th week 
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of pregnancy, it was observed that most of the participants obtained excellent support 
from family members (Khooshehchin, Keshavarz, Afrakhteh, Shakibazadeh & Faghihza-
deh 2016). According to a participant, she stated that, 
 
”My husband is a great supporter and really helps me. He says never think about bad 
things and try to be optimistic” (Frances) (Khooshehchin et al 2016) 
 
Some of the participants expressed their dismay in not receiving the support they nee-
ded from their loved ones (Khooshehchin et al 2016). Family support can be in the form 
of loved ones eating the same meal as the GDM woman, participating in the same physi-
cal activity, showing empathy.   
 
5.4.2 Healthcare Professionals Support 
Healthcare professionals can inspire pregnant women in improving self-efficacy for 
exercise through promoting physical activity in a group (Kaiser & Razurel 2013). It is of 
essence to encourage physical activity before pregnancy as it has been discovered that 
it reduces the risk of getting GDM  as mentioned earlier (Redden et al 2011). The risk of 
future diabetes, adverse effects of pregnancy and lifestyle modifications are managed 
when there is adequate support (Kaptein, Evans, McTavish, Banerjee, Feig, Lowe & 
Lipscombe 2015). Lack of support makes them defenseless (Devsam et al 2013) and is 
perceived as a prenatal risk factor and has adverse effects on gestation (Elsenbruch, 
Benson, Rucke, Rose, Dudenhausen, Pincus-Knackstedt, Klapp & Arck 2007). 
 
Family and healthcare professionals support improves treatment of GDM in a way that 
issues like depression, eating disorders, stress, anxiety are addressed and effectively 
managed (Magon & Seshiah 2011). Support ensures that the women with GDM are in safe 
hands (Devsam et al 2013).  
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6 Discussion 
6.1 Discussion of the findings 
GDM, a rampant health concern is seen to be on an increase through out the world and accounts 
for 90-95% of all cases in gestation (ADA 2009; Landon & Gabbe 2011). GDM as a result of glucose 
intolerance has led to complications for the mother, baby and infants. Maternal age over 30-35 
years, obesity, family history of GDM are some of the risk factors in pregnant women that nurses 
should pay attention to during screening at 24-28 weeks of pregnancy (Carolan 2013). 
 
All the 24 articles reviewed with the exception of one article concentrated on the general inter-
ventions by healthcare professionals but not on nursing interventions in the management of GDM 
as the research question states, ” What kind of nursing interventions are implemented in 
the management of gestational diabetes in prenatal care patients?”. Four main catego-
ries unfolded from the data analysis: self-care management, medication, education and 
training, and social support.  All the interventions deduced from the findings can be imple-
mented by nurses and are somehow connected, that is, it is impossible to discuss one without 
referring to the others.  
 
Nurses play a role in all the four main categories that were mentioned in the findings 
through education. Nurses are meant to provide clients with authentic, adequate, and 
up-to-date information in a culturally applicable manner (International Council of Nur-
ses (ICN) 2012, 2). Education of the clients is the key to attaining the interventions in 
the management of GDM in prenatal care. The GDM women are able to implement self-
care management (diet, exercise and self-monitoring) through the information they re-
ceive at the prenatal care centres in the form of leaflets, books, pregnancy app, coun-
seling sessions to mention but a few. There are some obstacles that prevent pregnant 
women with GDM from practicing these lifestyle interventions. According to Downs, 
Chasen-Taber, Evenson, Leiferman & Yeo (2012), during gestation, women experience 
difficulty in performing physical activity and eating well-balanced meal due to nausea, 
tiredness, dyspnea (shortness of breath), heartburn (due to gastric reflux), leg cramps, 
body soreness and inadequate time (Downs et al 2012). To overcome these barriers, so-
cial support has to be implemented which involves the family members, nurses and ot-
her healthcare professionals. Women without social support are exposed to stress and 
decreased self-care. GDM can be managed effectively and future T2DM prevented or 
even delayed if self-care management is adopted and general knowledge on GDM disse-
minated. 
 37 
 
Medication is usually introduced when diet fails to achieve the desired glycemia level. 
Nurses educate the clients on how to administer insulin or how to take the oral hy-
poglycemia agents as prescribed by the physician. Nurses should inform GDM women on 
the benefits of oral hypoglycemic agents over insulin and vice versa. 
 
Nurses can improve their professional growth through continual learning as explained in 
the findings. According to ICN (2012), they have a responsibility to themselves and to 
their clients to make certain that their nursing expertise is up-to-date (ICN 2012, 3). A 
default on the part of the nurses to update their knowledge endangers the lives of their 
clients thereby, countering the ethical responsibility of nurses to promote health, pre-
vent illness and to restore health (ICN 2012, 1). Management of GDM in prenatal care 
can be accomplished if nurses are open to novel knowledge. 
 
Nurses should inform GDM mothers about the written guidelines for exercise, diet, and 
weight management and the need to adhere to them. Weight loss meals are not pro-
posed during gestation but for overweight GDM women, IDF (2009) described that 30% 
reduction in energy intake does not result to ketosis (burning of fat instead of carbohyd-
rate for energy).  
 
In conclusion, effective management and reduction in the prevalence of GDM is through 
self-care management (diet, exercise and self-monitoring). A well-balanced diet 
through the Medical Nutrition Therapy (MNT) is a chief foundation of managing GDM. 
Nurses play an important role in counseling and educating women with GDM by provid-
ing indepth information on nutrition as stated by a clinical dietician. Nurses require fur-
ther education and training on the general knowledge, management and prevention of 
GDM so as to provide suitable guidance to the GDM women. 
 
6.2 Ethical Considerations 
Ethical consideration helps a researcher to emphasize the aim of research by conveying 
genuine data, with sincerity and avoiding error. Information acquired from research 
should be based on trust, mutual respect, accountability and fairness (Sudeshna & Datt 
2016). 
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As seen in the thesis, contributions of authors and researchers were recognized with 
either reference at the end of each sentence or ideas stated put in quotes (University of 
New South Wales, UNSW 2013). This is evidence that plagiarism was avoided at all cost. 
There was display of interest and full time involvement of participants at own will as we 
read through the findings in the 24 articles. 
Copyrights were highly respected as seen in the 30 articles with duplicates, triplicates 
and quadruplicates that were sorted and excluded as shown in figure 2. 
References were clearly written down as seen in laurea thesis guidelines to allow disclo-
sure of sources (Laurea.fi) 
 
6.3 Trustworthiness 
The concept trustworthiness involves the aspect of credibility and is defined as the 
”trustworthiness, verisimilitude and plausibility of the research” (Tracy 2010). Satyen-
dra & Srilata (2014) define credibility as “confidence in the trust of findings”. These 
authors discuss Lincoln and Guba (1985)’s characteristics on trustworthiness as credible, 
dependable, transferable and conformable. 
 
Credibility is a cornerstone of developing trustworthiness. It involves triangulation, ran-
dom sampling, adoption of research methods initiated in qualitative investigation, tac-
tics to ensure honesty in participants during data collection, negative case analysis, 
member checks, background, qualification and experience of the investigators (Lincoln 
and Guba 1985). 
 
The writers used a qualitative method of data collection called literature review for the 
thesis. 12,498 articles were attained by including articles with full text, peer review, 
English language and published from year 2007-2017 and in the end, 24 articles were 
accepted after the inclusion and exclusion approach as shown in figure 2, pg 18. With 
Johns Hopkins Evidence-Based Practice Model and Guidelines table 7, pg 22, the 24 arti-
cles were appraised using quality guidelines A, B OR C. It is only one article that was 
rated in category C hence concluding that information collected from these different 
articles were considered of quality and useful to the research question on GDM. 
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Different study groups were used in the research with same methods being experimen-
ted on how to manage GDM. This helped investigators to find out the various manage-
ment methods and their acceptability to the participants in order to reach a final con-
clusion, thus preventing investigator bias and promoting triangulation. 
 
Satyendra & Srilata (2014) linked conformability to objectivity and defined it as “the 
degree of neutrality or the extent to which findings of a study are shaped by respon-
dents but not research bias or interest” (Satyendra & Srilata 2014). As we read through 
the 24 articles, we discovered that it was participants’ decision to engage in the re-
search and those who opposed were not forced. This helped to ensure honesty from in-
formants and collection of facts. 
 
Each article presented the background, qualification and experience of the researchers 
thus considering them trustworthy to be used and the writers concluded that the diffe-
rent study findings in these 24 articles were eligible in the management of GDM.  
 
References used in some articles were seen in other articles with the same information 
in different countries. This showed that not only did other article writers trust the data 
collected from other sources but were able to use the data worldwide. The writers ag-
reed that the information was certified in answering the thesis topic because it was de-
pendable and transferable. Transferability was linked to external validity meaning that 
findings can be used in other contexts while dependability was linked to reliability im-
plying that findings are constant and can be replicated (Satyendra & Srilata 2014). 
 
6.4 Limitations 
Despite the fact that the aims and purpose of the research were attained, there were 
some unpreventable limitations. As novice writers, flaws are inevitable. 
Firstly, all the articles reviewed were carried out in both developed and developing 
countries (so many countries were involved) with different interventions in the mana-
gement of GDM.  
 
Secondly, with the literature search criteria being restricted to full text, english langu-
age and not older than ten years, some vital information may have been missed in arti-
cles written in other languages and older than ten years. Relevant data might have been 
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lost as well in articles without free access due to cost. The Laurea UAS does not have 
access to so many research portals thereby leading to loss of data in articles that could 
have been found in those sites.  
 
Thirdly, the articles reviewed were mainly level V with few II’s and III’s, thereby making 
the thesis lack high quality evidence materials. Further research is strongly needed to 
strengthen the results of this thesis. 
 
6.5 Recommendations 
From the findings, the writers recommend that nurses should receive adequate training 
on the management of GDM clients in prenatal care. Aspects such as language and cul-
ture should be put into consideration when educating both GDM pregnant women and 
professional healthcare team in order to have a good comprehension in the effective 
management of GDM . 
 
Furthermore, the literaure review used in this thesis was restricted to English language 
articles and developed and developing countries (with one article on Africa). The wri-
ters recommend further research to be conducted on studies carried out in Africa in or-
der to establish the validity of our findings. 
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Appendix 1: Data Extraction Form 
 
Authors, Year Title Level of Evidence (Johns 
Hopkins) 
Aim Conclusions 
Li, G., Björn, A., 
Hadziabdic, E., Hjelm, K. 
& Rask, M. (2016) 
Beliefs about health and 
illness and health-related 
behaviour among urban 
women with gestational 
diabetes mellitus in the 
south east of China 
Qualitative esplotratory 
study 
 
(Level III, Quality B) 
To explore beliefs about 
health and illness and 
health-related behaviour 
among urban Chinese 
women with GDM in a 
Chinese sociocultural 
context 
The womens’ beliefs 
were influenced by Chi-
nese culture. Certain cul-
tural aspects were bene-
ficial to them in terms of 
controlling their blood 
glucose for their babies’ 
health, obtaining family 
support, and reducing 
their stress from GDM 
Amin, M., Suksomboon, 
N., Poolsup, N. & Malik, 
O. (2015) 
Comparison of Glyburide 
with Metformin in Treat-
ing Gestational Diabetes 
Mellitus 
Systematic review and 
meta-analysis of random-
ized controlled trials 
 
(Level II, Quality B) 
To compare the efficacy 
and safety of glyburide 
with metformin in treat-
ing GDM 
Treatment of GDM with 
glyburide increases the 
risk of higher birth 
weight among infants 
making them prone to 
pregnancy complications 
such as shoulder dysto-
cia, birth trauma, and 
birth asphyxia. 
 
Metformin is seen to be 
an efficacious and better 
choice than glybuside in 
trating GDM 
Kachoria, R. & Oza-
Frank, R. (2014) 
Differences in Breast-
feeding Initiation by Ma-
ternal Diabetes Status 
Literature review 
 
(Level V, Quality A) 
To examine trends in 
breastfeeding at hospital 
discharge from 2006 to 
Breastfeeding initiation 
rates vary by diabetes 
status and race 
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and Race, Ohio 2006-2011 2011 by diabetes status  
 
To determine associa-
tions between brestfeed-
ing, diabetes status and 
maternal and infant 
characteristics 
 
Maternal characteristics 
affect women of differ-
ent races differently 
Halperin, I.J. & Feig, D.S. 
(2014) 
The Role of Life Interven-
tions in the Preventionof 
Gestational Diabetes 
Literature review 
 
(Level V, Quality A) 
To examine the epidemi-
ologic data linking 
healthy lifestyle choices 
to reduced risk of GDM 
 
T compare this with the 
interventional trials of 
diet and exercise to pre-
vent GDM 
Lifestyle interventions 
introduced in pregnancy 
have the potential to 
prevent the development 
of GDM and other compli-
cations 
Khooshehchin, T.E., 
Keshavarz, Z., Afrakhteh, 
M., Shakibazadeh, E. & 
Faghihzadeh, S. (2016) 
Perceived needs in wom-
en with gestational dia-
betes 
Qualitative study 
 
(Level III, Quality B) 
To describe facilitators 
and barriers that impact 
lifestyle modifications by 
women with gestational 
diabetes 
 
To gain an understanding 
of the ongoing prenatal 
and postpartum needs of 
women with GDM 
 
To discuss implications 
for best practices, health 
policies concerning dia-
betes prevention in “at 
risk” women 
It is essential to provide 
adequate support and 
education based on the 
culture and the perceived 
needs for the mothers 
with GDM and their fami-
ly members 
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Sahariah, S.A., Potdar, 
R.D., Gandhi, M., Kehoe, 
S.H., Brown, N., Sane, 
H., Coakley, P.J., Marley-
Zagar, E., Chopra, H., 
Shivshankaran, D., Cox, 
V.A., Jackson, A.A., Mar-
getts, B.M & Fall, C.H.D. 
(2016) 
A Daily Snack Containing 
Leafy Green Vegetables, 
Fruit, and Milk before 
and during Pregnancy 
Prevents Gestational Dia-
betes  
Randomized, Controlled 
Trial 
 
(Level II, Quality B) 
To test whether increas-
ing women’s dietary in-
take of leafy green vege-
tables, fruit, and milk 
before conception and 
throughout pregnancy 
reduced their risk of GDM 
Improving dietary micro-
nutrient quality by in-
cresing intake of leafy 
green vegetables, fruit, 
and/or milk may have an 
important protective ef-
fect against the devel-
opment of GDM 
Khan, T., Macaulay, S., 
Norris, S.A., Micklesfield, 
L.K. & Watson, E.D. 
(2016) 
Physical activity and the 
risk for gestational diabe-
tes mellitus amongst 
pregnant women iving in 
Soweto 
A cohort study 
 
(Level II, Quality C) 
To determine whether 
there is an association 
between physical activi-
ty, sedentary bahaviour 
and risk of GDM in preg-
nant black women living 
in urban Soweto in South 
Africa 
No conclusion available 
Doran, F. & Davis, K. 
(2010) 
Gestational diabetes 
mellitus in Tonga: in-
sights from healthcare 
professionals and women 
who experienced gesta-
tional diabetes mellitus 
Qualitative, individual, 
semi-structured, face-
toface interviews 
 
(Level III, Quality B) 
To gain contextual in-
sights from Tongan 
healthcare professional 
and women who had de-
veloped GDM 
GDM was reportedly well-
managed through life-
style interventions 
Borgen, I., Garnweidner-
Holme, L.M., Jacobsen, 
A.F., Bjerkan, K., Fay-
yad, S., Joranger, P., Lil-
leengen, A.M., Mosdøl, 
A., Noll, J., Småstuen, 
M.C., Terragni, L., 
Torheim, L.E. & Lukasse, 
M. (2017) 
Smartphone application 
for women with gesta-
tional diabetes mellitus 
A randomized controlled 
trial 
 
(Level II, Quality A) 
To access whether the 
use of the pregnancy+ 
app in addition to stand-
ard care results in better 
glucose levels at routine 
OGTT, 3 months postpar-
tum, compared with 
standard care only 
Smartphone for GDM is 
useful in managing GDM 
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Chen, P., Wang, S., Ji, 
J., Ge, A., Chen, C., Zhu, 
Y., Xie, N. & Wang, Y. 
(2015) 
Risk factors and Manage-
ment of Gestational Dia-
betes 
Literature review 
 
(Level V, Quality A) 
To highlight the various 
risk factors associated 
with GDM along with the 
available therapeutic op-
tions in the treatment 
and management of the 
disease 
A modification of lifestyle 
along with insulin therapy 
can sufficiently aid in the 
treatment and control of 
GDM 
Ashwal, E. & Hod, M. 
(2015) 
Gestational diabetes 
mellitus: Where are we 
now? 
Literature review 
 
(Level V, Quality A) 
No aim available Pharmacological treat-
ment (insulin or oral anti-
diabetic drugs) reduces 
fetal maternal morbidity 
and mortality related 
with GDM 
Bone, R.L. (2015) Big Babies: An Explora-
tion of Gestational Diabe-
tes 
Literature review 
 
(Level V, Quality B) 
No aim available In order to eradicate 
mother-daughter cycle of 
GDM, maintaining an ide-
al body weight through 
diet and/or physical ex-
ercise in the postpartum 
phase is imperative. 
Mays, L. (2014) Gestational Diabetes and 
Postpartum Metabolic 
Syndrome 
Literature review 
 
(Level V, Quality A) 
To promote positive 
health outcomes for 
women with GDM through 
childbirth educators 
Healthy behaviours such 
as diet, exercise, and 
breastfeeding decreases 
the chances of negative 
health outcomes such as 
the development of met-
abolic syndrome. 
Javid, F.M., Simbar, M., 
Dolatian, M., Majg, H.A. 
& Mahmoodi, Z. (2016) 
A Comparative Study and 
Physical Activity of Wom-
en With and Without Ges-
tational Diabetes 
A comparative (case and 
control group) 
 
(Level II, Quality A) 
To determine and com-
pare dietary style and 
physical activity in wom-
en with gestational dia-
betes and healthy preg-
Gestational diabetes can 
be prevented by appro-
priate counseling and 
making pregnant women 
aware of having an ap-
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nant women propriate and healthy 
lifestyle during pregnancy 
by the midwife  
Magon, N. & Seshiah, V. 
(2011) 
Gestational diabetes 
mellitus: Non-insulin 
management 
Literarure review 
 
(Level V, Quality A) 
To improve pregnancy 
outcomes  
 
To promote healthy life-
style changes for the 
mother that will last long 
after delivery 
MNT is the most common 
therapy which suffices 
for GDM. Pharmacological 
treatment is considered if 
deemed necessary 
Whitehouse, K. (2010) Organization of antenatal 
care 
Literature review 
 
(Level V, Quality A) 
To identify high-risk 
women who will require 
obstetric-led care 
Antenatal care provides 
information, support and 
monitoring during the 
physiological course of 
pregnancy 
Hirst, J.E., Mackillop, L., 
Loerup, L., Kevat, D.A., 
Bartlett, K., Gibson, O., 
Kenworthy, Y., Levy, 
J.C., Tarassenko, L. & 
farmer, A. (2015) 
Acceptability and user 
satisfaction of a 
smartphone-based, inter-
active blood glucose ma-
nagement system in wo-
men with gestational dia-
betes mellitus 
Pilot study 
 
(Level III, Quality A) 
To determine women’s 
satisfaction with using 
the GDm-health system 
and their attitudes to-
ward their diabetes care 
GDm-health is acceptable 
and convenient for a 
large proportion of wom-
en 
Cheng, Y.W. & Caughey, 
A.B. (2008) 
Gestational diabetes: di-
agnosis and management 
Literature review 
 
(Level V, Quality A) 
To review the diagnosis 
and management of ges-
tational diabetes 
Frequent blood glucose 
monitoring, nutrition 
counselling and frequent 
physician contact allow 
for individualized care to 
achieve optimal out-
comes 
Perera, O.P., Nakash, 
M.B., Covarrubias, A.P., 
Cano, A.R., Torres, A.R., 
A Medical Nutrition Ther-
apy Program Improves 
Perinatal Outcomes in 
Quasi-experimental de-
sign 
 
To assess the effect of a 
medical nutrition therapy 
(MNT) program on perina-
An intensive MNT pro-
gram, including counsel-
ing, education, and capil-
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Gonzalez, C.O. & Ortega, 
F.V. (2009) 
Mexican Pregnant Women 
with Gestational Diabetes 
and Type 2 Diabetes 
Mellitus  
(Level II, Quality A) tal complications in Mexi-
co City 
lary glucose self-
monitoring has a positive 
effect over preeclampsia, 
maternal hospitalization, 
and neonatal death in 
women with diabetes in 
pregnancy 
Melamed, N. & Yogev, Y. 
(2009) 
Can pregnant diabetics 
be treated with gly-
buride: 
Literature review 
 
(Level V, Quality A) 
To determine the effica-
cy of glyburide 
Owing to its ease of ad-
ministration, convenience 
and low cost, glyburide 
will become the first line 
of medical treatment in 
patients with GDM within 
the next few years 
Reece, E.A., Leguizamón, 
G. & Wiznitzer, A. (2009) 
Gestational diabetes: the 
need for a common 
ground 
Literature review 
 
(Level A, Quality B) 
To report the controver-
sies surrounding the 
causes, screening, diag-
nosis, management, and 
preventionof gestational 
diabetes 
Screening, early detec-
tion, and management 
can greatly improve out-
comes for women with 
this condition and their 
babies 
Rigla, M., Martinez-
Sarriegui, I., Garcia-Saez, 
G., Pons, B. & Hernando, 
M.E. (2017) 
Gestational Diabetes 
Management Using Smart 
Mobile Telemedicine 
Pilot study 
 
(Level III, Quality B) 
To test the feasibility and 
acceptance of a mobile 
decision-support system 
for GDM 
Artificial-intelligence-
augumented telemedi-
cine can offer a good al-
ternative, saving re-
sources while maintaining 
the standards of care 
proposd in the clinical 
guidelines 
Hyer, S., Balani, J., 
Johnson, A. & Shehata, 
H. (2009) 
Metformin treatment for 
gestational diabetes 
Literature review 
 
(Level V, Quality A) 
To describe the experi-
ence with metformin in 
GDM and review the ex-
perience 
Offering of metformin to 
GDM women where life-
style measures are inad-
equate to achieve 
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euglycaemia has resulted 
in a considerable easing 
of the workload burden 
for the diabetes special-
ist nurses who previously 
had large numbers of 
women at each clinic for 
initiation of insulin 
treatment 
Thung, S.F. & Landon, 
M.B. (2013) 
Managing gestational dia-
betes: timing, selection 
and use of pharma-
cotherapy 
Literature review 
 
(Level V, Quality B) 
To present the available 
data to help providers 
understand what thera-
pies are available, their 
unique strengths and 
weaknesses 
 
To initiate and escalate 
doses to achieve mater-
nal euglycemia 
Metformin reduces per-
pheral insulin resistance. 
Glyburide enhances insu-
lin secretion. 
 
 
 
